OAZ2 and neoplasm: Furthermore, Li et al. highlighted that OAZ2 is a direct downstream target of the tumor-suppressor miR-34a, and its overexpression can mitigate the chemosensitivity impairment caused by miR-34a deficiency in colon cancer13.